Literature DB >> 24648921

Salvianolic acid A positively regulates PTEN protein level and inhibits growth of A549 lung cancer cells.

Lei Bi1, Jianping Chen2, Xiaojing Yuan2, Zequn Jiang2, Weiping Chen2.   

Abstract

Salvianolic acid A (Sal A) is an effective compound extracted from Salvia miltiorrhiza which has been used in the treatment of various diseases. Preliminary data indicate that Sal A treatment has a specific anti-lung cancer effect. However, the manner in which Sal A regulates cancer growth remains unknown. In this study, the A549 lung cancer cell line and its response to Sal A treatment was examined. Results showed that Sal A treatment significantly decreased A549 cell growth, promoted partial apoptosis and increased mitochondrial membrane permeability. Western blot analysis showed that Sal A upregulated the phosphatase and tensin homolog (PTEN) protein level, while consistently downregulating Akt phosphorylation. These results indicate that Sal A negatively mediates A549 lung cancer cell line growth or apoptosis, most likely by positively regulating PTEN protein level.

Entities:  

Keywords:  Akt phosphorylation; apoptosis; phosphatase and tensin homolog; salvianolic acid A

Year:  2012        PMID: 24648921      PMCID: PMC3956209          DOI: 10.3892/br.2012.33

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  16 in total

Review 1.  [Research progress of salvianolic acid A].

Authors:  Li Zhang; Weiku Zhang; Ying Zhao; Xiuying Yang; Lianhua Fang; Shoubao Wang; Lili Shi; Xiaoyan Yu; Subo Wang; Haiguang Yang; Jialin Sun; Shuo Tian; Guanhua Du
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2011-10

Review 2.  PI3K-Akt pathway: its functions and alterations in human cancer.

Authors:  M Osaki; M Oshimura; H Ito
Journal:  Apoptosis       Date:  2004-11       Impact factor: 4.677

3.  Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition.

Authors:  Shinji Saiki; Yukiko Sasazawa; Yoko Imamichi; Sumihiro Kawajiri; Takahiro Fujimaki; Isei Tanida; Hiroki Kobayashi; Fumiaki Sato; Shigeto Sato; Ken-Ichi Ishikawa; Masaya Imoto; Nobutaka Hattori
Journal:  Autophagy       Date:  2011-02-01       Impact factor: 16.016

4.  [Salvianolic acid A inhibits nucleoside transport and potentiates the antitumor activity of chemotherapeutic drugs].

Authors:  Sheng-Hua Zhang; Jian Su; Yong-Su Zhen
Journal:  Yao Xue Xue Bao       Date:  2004-07

Review 5.  Induction of Akt activity by chemotherapy confers acquired resistance.

Authors:  Wei-Chien Huang; Mien-Chie Hung
Journal:  J Formos Med Assoc       Date:  2009-03       Impact factor: 3.282

Review 6.  PTEN regulatory functions in tumor suppression and cell biology.

Authors:  Eric C Chu; Andrzej S Tarnawski
Journal:  Med Sci Monit       Date:  2004-09-23

Review 7.  PTEN function: how normal cells control it and tumour cells lose it.

Authors:  Nick R Leslie; C Peter Downes
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

Review 8.  The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.

Authors:  Amancio Carnero; Carmen Blanco-Aparicio; Oliver Renner; Wolfgang Link; Juan F M Leal
Journal:  Curr Cancer Drug Targets       Date:  2008-05       Impact factor: 3.428

9.  Requirement of phosphatidylinositol(3,4,5)trisphosphate in phosphatidylinositol 3-kinase-induced oncogenic transformation.

Authors:  Adam Denley; Marco Gymnopoulos; Sohye Kang; Christina Mitchell; Peter K Vogt
Journal:  Mol Cancer Res       Date:  2009-07-07       Impact factor: 5.852

10.  AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines.

Authors:  Sandra Koseoglu; Zhuomei Lu; Chandra Kumar; Paul Kirschmeier; Jun Zou
Journal:  Cancer Biol Ther       Date:  2007-02-09       Impact factor: 4.742

View more
  10 in total

1.  Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods.

Authors:  Leilei Liu; Ping Zhan; Xiaodie Zhou; Yong Song; Xiaojun Zhou; Like Yu; Jiandong Wang
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

2.  Cytotoxic effects of solvent-extracted active components of Salvia miltiorrhiza Bunge on human cancer cell lines.

Authors:  Bokyung Sung; Hye Sun Chung; Minjung Kim; Yong Jung Kang; Dong Hwan Kim; Seong Yeon Hwang; Min Jo Kim; Cheol Min Kim; Hae Young Chung; Nam Deuk Kim
Journal:  Exp Ther Med       Date:  2015-02-03       Impact factor: 2.447

3.  The component formula of Salvia miltiorrhiza and Panax ginseng induces apoptosis and inhibits cell invasion and migration through targeting PTEN in lung cancer cells.

Authors:  Lei Bi; Xiaojing Yan; Ye Yang; Lei Qian; Yuan Tian; Jian-Hua Mao; Weiping Chen
Journal:  Oncotarget       Date:  2017-09-28

4.  Salvianolic Acid A, as a Novel ETA Receptor Antagonist, Shows Inhibitory Effects on Tumor in Vitro.

Authors:  Qiao Zhang; Shifeng Wang; Yangyang Yu; Shengnan Sun; Yuxin Zhang; Yanling Zhang; Wei Yang; Shiyou Li; Yanjiang Qiao
Journal:  Int J Mol Sci       Date:  2016-08-02       Impact factor: 5.923

5.  Systematic Understanding of the Mechanism of Salvianolic Acid A via Computational Target Fishing.

Authors:  Shao-Jun Chen; Ming-Chao Cui
Journal:  Molecules       Date:  2017-04-17       Impact factor: 4.411

Review 6.  Salvianolic acid A & B: potential cytotoxic polyphenols in battle against cancer via targeting multiple signaling pathways.

Authors:  Tian Qin; Azhar Rasul; Ayesha Sarfraz; Iqra Sarfraz; Ghulam Hussain; Haseeb Anwar; Ammara Riaz; Sitong Liu; Wei Wei; Jiang Li; Xiaomeng Li
Journal:  Int J Biol Sci       Date:  2019-08-19       Impact factor: 6.580

7.  miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway.

Authors:  Wu Yang; Wei Xiao; Zhengrong Cai; Shidai Jin; Tian Li
Journal:  Onco Targets Ther       Date:  2020-01-07       Impact factor: 4.147

8.  Salvianolic acid B acts against non‑small cell lung cancer A549 cells via inactivation of the MAPK and Smad2/3 signaling pathways.

Authors:  Guanglei Han; Yongzhong Wang; Tong Liu; Jiarong Gao; Fengyi Duan; Ming Chen; Yan Yang; Chao Wu
Journal:  Mol Med Rep       Date:  2022-03-29       Impact factor: 2.952

Review 9.  PTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literature.

Authors:  Jian Xiao; Cheng-Ping Hu; Bi-Xiu He; Xi Chen; Xiao-Xiao Lu; Ming-Xuan Xie; Wei Li; Shu-Ya He; Shao-Jin You; Qiong Chen
Journal:  Oncotarget       Date:  2016-09-06

10.  MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route.

Authors:  Butong Sun; Nanjun Hu; Dan Cong; Kang Chen; Jun Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.